ערך בספרים למניה: Biote (BTMD)

biote Corp. (BTMD) leads the bioidentical hormone therapy segment, establishing a resilient B2B infrastructure through medical center certification, which ensures a stable cash flow. The company minimizes risks by offering services for both genders and selling dietary supplements. This daily price action on GURU.Markets reflects a value of -2.40. Business growth is based on the expansion of the clinic network and targeted international franchising without engaging in merger and acquisition deals.

biote Corp.'s leadership in the hormone optimization segment and its physician training programs create a sustainable active basis that directly impacts asset capitalization. The trend in total book value per share reflects the difference between total assets and liabilities, allowing investors to assess the real value of a single share regardless of market speculation and price volatility.